Clovis Oncology Announces Third Quarter 2020 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- L3Harris CEO steps down amid conduct review, shares drop
Clovis Oncology (CLVS) Tops Q3 EPS by 10c
November 5, 2020 8:18 AM ESTClovis Oncology (NASDAQ: CLVS) reported Q3 EPS of ($0.89), $0.10 better than the analyst estimate of ($0.99). Revenue for the quarter came in at $38.8 million versus the consensus estimate of $42.64 million.
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
... More